Reneo Pharmaceuticals, Inc. (RPHM) NASDAQ

18.20

+16.47(+952.02%)

Updated at October 04, 2024 04:00PM

Currency In USD

Valuation

Market Cap627.37M
Enterprise Value517.69M
P/E Ratio65.95
PEG Ratio-0.11
Price/Sales Ratio-82.89
Price/Book Ratio37.07
Enterprise/Revenue11.99
Enterprise/EBITDA-3.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-50.87
Operating Margin83.4

Management Effectiveness

Return On Assets0.51
Return On Equity0.44

Income Statement

Revenue0
Revenue/Share-0.01
Gross Profit0
EBITDA-54.39M
Net Income0
Diluted EPS0

Balance Sheet

Total Cash70.33M
Total Cash/Share0.52
Total Debt687,000
Total Debt/Equity0.01
Current Ratio11.45
Book Value Per Share0.49

Price History

52-Week Change-76.67
52-Week High82.9
52-Week Low1.68
Moving Average 50 Days14.92
Moving Average 200 Days16.09

Statistics

Average Volume17,983
Shares Outstanding3.34M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 07, 2024